Pharmaceutical wholesaler H. D. Smith, Springfield, IL, has acquired the remaining 49 percent of shares in Triplefin, a reimbursement, patient assistance and pharmaceutical brand-support services company headquartered in Cincinnati, OH. H. D. Smith secured majority representation on Triplefin's board of directors in January and majority stock ownership interest in May.
Triplefin will operate as a wholly owned subsidiary of H. D. Smith within the H. D. Smith Specialty Solutions operating unit. Terms were not disclosed.